Your search for Antineoplastic and immunomodulating agents
Number of alerts found: 114

2023/0491- OFATUMUMAB [20 MG/0.4 ML; SOL INJ; CANETA]

OFATUMUMAB [20 MG/0.4 ML; SOL INJ; CANETA] OFATUMUMAB [20 MG/0.4 ML; SOL INJ; CANETA]

CPV: 33652000 Antineoplastic and immunomodulating agents
Place of execution:
2023/0491- OFATUMUMAB [20 MG/0.4 ML; SOL INJ; CANETA]
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000255
Publication:
July 2, 2025, 10:21 a.m.
2023/0491-ENCORAFENIB [75 MG; CÁP/COMP]

ENCORAFENIB [75 MG; CÁP/COMP] ENCORAFENIB [75 MG; CÁP/COMP]

CPV: 33652000 Antineoplastic and immunomodulating agents
Place of execution:
2023/0491-ENCORAFENIB [75 MG; CÁP/COMP]
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000237
Publication:
July 2, 2025, 10:12 a.m.
2023/0491- PONATINIB [15 MG; CÁP/COMP]

PONATINIB [15 MG; CÁP/COMP] PONATINIB [15 MG; CÁP/COMP]

CPV: 33652000 Antineoplastic and immunomodulating agents
Place of execution:
2023/0491- PONATINIB [15 MG; CÁP/COMP]
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000344
Publication:
July 2, 2025, 10:12 a.m.
2023/0491- GOLIMUMAB [50 MG/0.5 ML; SOL INJ; CANETA/SERINGA]

GOLIMUMAB [50 MG/0.5 ML; SOL INJ; CANETA/SERINGA] GOLIMUMAB [50 MG/0.5 ML; SOL INJ; CANETA/SERINGA]

CPV: 33652000 Antineoplastic and immunomodulating agents
Place of execution:
2023/0491- GOLIMUMAB [50 MG/0.5 ML; SOL INJ; CANETA/SERINGA]
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000166
Publication:
July 2, 2025, 10 a.m.
2023/0491 - INTERFERÃO BETA-1A [6 MUI; 0,5 ML; IM; CANETA]

INTERFERÃO BETA-1A [6 MUI; 0,5 ML; IM; CANETA] INTERFERÃO BETA-1A [6 MUI; 0,5 ML; IM; CANETA]

CPV: 33652000 Antineoplastic and immunomodulating agents
Place of execution:
2023/0491 - INTERFERÃO BETA-1A [6 MUI; 0,5 ML; IM; CANETA]
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000160
Publication:
July 2, 2025, 9:47 a.m.
2023/0491- IBRUTINIB [560 MG; CÁP/COMP]

IBRUTINIB [560 MG; CÁP/COMP] IBRUTINIB [560 MG; CÁP/COMP]

CPV: 33652000 Antineoplastic and immunomodulating agents
Place of execution:
2023/0491- IBRUTINIB [560 MG; CÁP/COMP]
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000166
Publication:
July 2, 2025, 9:36 a.m.
2023/0491- DURVALUMAB [50 MG/ ML; 10 ML; FRS]

DURVALUMAB [50 MG/ ML; 10 ML; FRS] DURVALUMAB [50 MG/ ML; 10 ML; FRS]

CPV: 33652000 Antineoplastic and immunomodulating agents
Place of execution:
2023/0491- DURVALUMAB [50 MG/ ML; 10 ML; FRS]
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000136
Publication:
July 2, 2025, 9:31 a.m.
2023/0491- IBRUTINIB [560 MG; CÁP/COMP]

IBRUTINIB [560 MG; CÁP/COMP] IBRUTINIB [560 MG; CÁP/COMP]

CPV: 33652000 Antineoplastic and immunomodulating agents
Place of execution:
2023/0491- IBRUTINIB [560 MG; CÁP/COMP]
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000314
Publication:
July 2, 2025, 9:26 a.m.
2023/0491- PONATINIB [15 MG; CÁP/COMP]

PONATINIB [15 MG; CÁP/COMP] PONATINIB [15 MG; CÁP/COMP]

CPV: 33652000 Antineoplastic and immunomodulating agents
Place of execution:
2023/0491- PONATINIB [15 MG; CÁP/COMP]
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000160
Publication:
July 2, 2025, 9:19 a.m.
2023/0491- NINTEDANIB [100MG; CÁPS]

NINTEDANIB [100MG; CÁPS] NINTEDANIB [100MG; CÁPS]

CPV: 33652000 Antineoplastic and immunomodulating agents
Place of execution:
2023/0491- NINTEDANIB [100MG; CÁPS]
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000145
Publication:
July 2, 2025, 9:16 a.m.